|
Price and Volume
Detailed Quote
Compare to:
|
Top News
More News
A new class of anti-cancer drugs that allow the immune system to attack cancer cells are generating considerable excitement among patients, doctors, and investors. New results being released ahead of... Read More
from Forbes Real Time
|